Your browser doesn't support javascript.
loading
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study.
Nakano, Shintaro; Yuki, Satoshi; Kawamoto, Yasuyuki; Nakatsumi, Hiroshi; Ando, Takayuki; Kajiura, Shinya; Yoshikawa, Ayumu; Harada, Kazuaki; Hatanaka, Kazuteru; Tanimoto, Aya; Ishiguro, Atsushi; Honda, Takuya; Dazai, Masayoshi; Sasaki, Takahide; Sakamoto, Naoya; Komatsu, Yoshito.
Afiliação
  • Nakano S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Kawamoto Y; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Nakatsumi H; Division of Cancer Center, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Ando T; Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama, 930-0194, Japan.
  • Kajiura S; Department of Gastroenterology and Hematology, Faculty of Medicine, University of Toyama, 2630, Sugitani, Toyama-shi, Toyama, 930-0194, Japan.
  • Yoshikawa A; Department of Medical Oncology, Kushiro Rosai Hospital, 13-23 Nakazono-cho, Kushiro, Hokkaido, 085-8533, Japan.
  • Harada K; Department of Medical Oncology, Kushiro Rosai Hospital, 13-23 Nakazono-cho, Kushiro, Hokkaido, 085-8533, Japan.
  • Hatanaka K; Department of Gastroenterology, Hakodate Municipal Hospital, 1-10-1 Minatomachi, Hakodate, Hokkaido, 041-8680, Japan.
  • Tanimoto A; Department of Medical Oncology, Teine Keijinkai Hospital, 1-40, Maeda1-12, Teine-Ku, Sapporo, Hokkaido, 006-8555, Japan.
  • Ishiguro A; Department of Medical Oncology, Teine Keijinkai Hospital, 1-40, Maeda1-12, Teine-Ku, Sapporo, Hokkaido, 006-8555, Japan.
  • Honda T; Division of Clinical Oncology Center, Nagasaki University Hospital, 1-7-1, Sakamoto, Nagasaki, 852-8501, Japan.
  • Dazai M; Department of Gastroenterology, Sapporo Medical Center NTT EC, Minami1, Nishi5, Chuo-Ku, Sapporo, Hokkaido, 060-0061, Japan.
  • Sasaki T; Department of Internal Medicine, Hokkaido Gastroenterology Hospital, 2-10, Honcho1-1, Higashi-Ku, Sapporo, Hokkaido, 065-0041, Japan.
  • Sakamoto N; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan.
  • Komatsu Y; Division of Cancer Center, Hokkaido University Hospital, Kita14, Nishi5, Kita-Ku, Sapporo, Hokkaido, 060-8648, Japan. ykomatsu@ac.cyberhome.ne.jp.
Int J Clin Oncol ; 25(10): 1800-1806, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32666389
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Glucuronosiltransferase / Irinotecano Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Glucuronosiltransferase / Irinotecano Idioma: En Ano de publicação: 2020 Tipo de documento: Article